Cargando…
Plasma sICAM-1 Correlates with Tumor Volume Before Primary Radiochemotherapy of Head and Neck Squamous Cell Carcinoma Patients
BACKGROUND: Biomarkers are of major interest to optimize diagnosis, prognosis and to guide treatment in head and neck cancer patients. Especially blood-based biomarkers appear promising as they can be easily collected and repeatedly analyzed during the course of radiochemotherapy. PATIENTS AND METHO...
Autores principales: | Clasen, Kerstin, Welz, Stefan, Faltin, Heidrun, Zips, Daniel, Eckert, Franziska |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784360/ https://www.ncbi.nlm.nih.gov/pubmed/36503712 http://dx.doi.org/10.2478/raon-2022-0043 |
Ejemplares similares
-
Dynamics of HMBG1 (High Mobility Group Box 1) during radiochemotherapy correlate with outcome of HNSCC patients
por: Clasen, Kerstin, et al.
Publicado: (2021) -
Impact of MRI on target volume definition in head and neck cancer patients
por: Clasen, Kerstin, et al.
Publicado: (2023) -
TNF-α and sICAM-1 in intracranial aneurismal rupture
por: Witkowska, Anna Maria, et al.
Publicado: (2009) -
Release of sICAM-1 in Oocytes and In Vitro Fertilized Human Embryos
por: Borgatti, Monica, et al.
Publicado: (2008) -
The TARC/sICAM5 Ratio in Patient Plasma is a Candidate Biomarker for Drug Resistant Epilepsy
por: Pollard, John R., et al.
Publicado: (2013)